DACE (@DACE0325) header
DACE (@DACE0325) profile picture

The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions.

NC
Joined March 2014
DACE retweeted
$AIMN AimwellBio just opened public nominations for healthcare pros to feature in 2027 coverage while rolling out free AI Visibility Scans so physicians can see exactly what AI says about them. 🩺 Verified intelligence + Trustr behavioral AI + expanding physician network (incl. GLP-1 cohort) is gaining real traction. 🚀 Watching: $HIMS $DNA $CRDL $NICH $MRNA #AIMN #Biotech #HealthcareAI #AI #OTC
2
2
101
Expecting multiple updates this week to happen here and via formal PR as we continue to grow and expand through negotiations $AIMN
4
6
15
1,439
$AIMN 👀
Expecting multiple updates this week to happen here and via formal PR as we continue to grow and expand through negotiations $AIMN
1
4
172
Would you trust a healthcare AI answer if you couldn’t see the evidence behind it? AimwellBio ($AIMN) is building the Verdict Layer to test AI-generated health answers and show the evidence behind its assessments. Follow $AIMN for updates as we build.
2
1
6
422
With the weight of “crushing debt obligations” now being restructured requiring 98% (+/-) less shares to satisfy. This is good for future M&A as we look to grow in the space without that monkey on our backs. New debt holder is very reasonable and wants to see growth $AIMN
2
1
11
439
Awesome to see this. Really excited about the 1-person biotech in particular. CROs with APIs available for agents like @ginkgo’s Datapoints service plus something like a “cursor for biotech” could really change the cost of launching biotech startups.
Over the past few months, Anthropic scientists have engaged in deep research partnerships with six organizations developing new medicines. We've also begun drug discovery efforts of our own. In doing so, we’ve learned much more about how Claude can support the many stages of drug development. In this blog post, we share some early results from these efforts, and describe how this work fits in with our wider ambitions in the life sciences. anthropic.com/research/early…
10
5
1
106
6,583
$DNA FORMER OPENAI EXEC KEVIN WEIL SIGNALS INTEREST IN COLLABORATING WITH GINKGO BIOWORKS ($DNA) ON AI-POWERED DRUG DISCOVERY FOLLOWING LAUNCH OF WARP SCIENCES — X
2
8
4,990
Great to see the leadership from @SecScottBessent adding biotechnology to the COINS Act list of strategic technologies. We've been hollowing out the US biotechnology startup ecosystem with newly acquired drugs originating in Chinese startups going from roughly 0% to 50% over the last 5 years. This puts US control of the frontier of biotechnology at risk in exchange for lower cost scientist labor and looser clinical trial regulations in China. To add insult to injury -- US patients are the source of 70-80% of the *worldwide* profits in pharmaceuticals! The US spends $700B per year on the newest, branded drugs while China only spends $60B per year on the same drugs with 4X the population! If the CCP wants to control the frontier of biotech there is an easy way to do it -- they should pay a fair price for pharmaceuticals to support a domestic ecosystem. But the CCP requiring that Chinese patients pay 1/10th to 1/40th the price for the same drugs compared to US patients (meanwhile iPhones are more expensive in China!) while also trying to offshore a dual use strategic technology is way across the line. Well done by Treasury in waking up to this bad deal for the US and starting the remedy. Huge win today for US biotechnology ("little pharma") and national security 👏👏👏
The regs are out: Prohibited tech includes pharmaceutical compounds, including a number of important modalities as examples
3
10
4
75
11,531
DACE retweeted
$NWPG 🚀 NFI Empire’s Project REBORN-001 is stacking elite partners! House of Kolor named official paint partner + Smokey Road Rod Shop reinventing the bed, Second Skin Audio on sound deadening, and HSP Diesel as engine performance partner donating custom powder-coated components. Classic 1979 K30 + modern Duramax heading to charity auction for The Brett Boyer Foundation. Momentum building with digital auction platform ahead. 💪🔥 $ECDA $PREC $HLLY $FOXF $PII $HOG $THO $WGO $CWH $KNDI $OSK #NWPG #NFIEmpire #ProjectREBORN #Automotive #OTC #Bullish
1
1
91
DACE retweeted
$NWPG NFI Empire’s Project REBORN-001 is stacking elite partners House of Kolor official paint, Smokey Road Rod Shop reinventing the bed, Second Skin Audio on sound, HSP Diesel on performance. Classic 1979 K30 + modern Duramax headed to charity auction for The Brett Boyer Foundation. Digital auction platform next. Momentum building. 🚀🔥 $ECDA $PREC $HLLY $FOXF #NWPG #NFIEmpire #ProjectREBORN #Automotive #OTC
2
3
85
Fun having @bryan_johnson by @Ginkgo ! Lucky to have his early support and robotic labs + AI agents in your pocket open the door to lots of new ways to approach wellness and longevity. Going to be fun coming up in this space !
Maintaining health during 10 days on the road > to washington dc speaking with politicians > america by design launch > @drmichaellevin lab deep dive > @Ginkgo AI automated biology lab > tobi lutke car racing
2
7
1
63
5,577
Even in medicine there is a crazy difference in risk tolerance between new surgical procedures vs new drug development. The big unlock of n=1 drug development could be moving towards a regulatory regime more like surgery (or like driving cars, etc) for medicine development. If the impact is to only one person we accept a lot of risk and free choice in society. Will need to drop the cost of drug development so it is closer to the cost of surgery (and here drug development will just be research and manufacturing, not trials since they aren’t needed for n=1) We will also need “biotech doctors” or something equivalent but the baby KJ story paves the way.
Anthropic's proposed AI safety bill sets "killing or seriously injuring more than 50 people" as the risk threshold for blocking the release of an AI model In contrast, when a single patient (Jesse Gelsinger) died in a gene therapy clinical trial in 1999: - The institute that ran the trial was dissolved - The senior scientist running the trial was banned from clinical work for 5 years - Gene therapy saw deep cuts in funding and research activity for a decade Tech and biotech have just profoundly different cultures of risk. As AI companies increasingly engage with biomedical research, a culture clash is inevitable politico.com/news/2026/10/16…
5
7
56
3,869
$NICH slow and steady. Updates coming per co twitter 👀 $NXGB hit 005 this morning 1 billion share retirement 🔥
1
7
281
$NICH sounds like updates coming 👀
More updates to come on this as we get closer to closing on the restructure. Thank you for your attention to this matter. $NICH
1
6
265
$AIMN dip getting soaked. $NICH hardly anything out there
1
6
187
Bingo. If we want to keep biotech in the US -- robotics is the way. Automate the lab bench or lose it.
It’s really simple. Our Robots and AI vs their Robots and AI. If we can catch up on robotics/software , and can stay ahead on AI, there is zero reason manufacturing won’t come back, or initiate here. At Cost Plus Drugs, the only thing holding us back from making generic drugs cheaper in Dallas than we can buy from Asia, are the fees we have to pay.
5
11
2
68
4,001